MedApp has signed an agreement with StethoMe, a start-up developer of a solution for remote detection of respiratory abnormalities. As part of the partnership, MedApp’s digital medicine application will support a wireless stethoscope. The new device will expand the range of tests offered by medical facilities using CarnaLife System and Digital Clinic solutions.
StethoMe is the first solution for remote detection of abnormalities in the respiratory system. It is based on artificial intelligence algorithms with medical device status, working with a wireless stethoscope and adedicated application. With unique technologies to ensure the test’s quality, it can be used by patients remotely. The solution is particularly useful for people with conditions such as asthma, chronic obstructive pulmonary disease, diabetes, pneumonia, bronchitis and other respiratory conditions.
“StethoMe is one of the most innovative solutions available in the medical market today. We look forward to working together with the StethoMe team to deploy it at our partner facilities and enhance our app and services. Already, CarnaLife System and the Digital Clinic offer a wide spectrum of measurements and their analysis in the areas of internal medicine, cardiology or diabetology. With a wireless stethoscope, physicians from facilities using our solutions will be able to check the respiratory status of patients without making appointments. All remotely,” summarizes Krzysztof Mędrala, CEO of MedApp.
Read more See similar articles:
The results generated in H1 2021 by MedApp S.A. are similar to the results the Company achieved for the whole of 2020. The interview with Krzysztof Mędrala, CEO of MedApp S.A.
In connection with the publication of the Interim Report for Q2 2021 on September 12, 2021, we invite you to watch the interview with Krzysztof Mędrala, CEO of MedApp S.A. according to Company’s activities realized in the reporting period and the financial results achieved in H1 2021.
MedApp significantly increases its business scale in Q2 2021.
The Cracow-based company, offering innovative technological solutions in medicine (medtech), achieved a net result in the first half of this year, similar to the level for the whole of last year.